China Pharma Holdings (CPHI) Share-based Compensation (QoQ) (2010 - 2026)
China Pharma Holdings (CPHI) Share-based Compensation (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | China Pharma Holdings | 629,344.02 | 460,870.02 | 285,487.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.08% |
| Mar 31, 2024 | 432.93% |
| Dec 31, 2023 | -121.57% |
| Sep 30, 2023 | 487.13% |
| Jun 30, 2023 | -175.55% |
| Mar 31, 2023 | -35.48% |
| Dec 31, 2022 | 403.73% |
| Sep 30, 2022 | 0.00% |
| Jun 30, 2022 | -33.33% |
| Mar 31, 2022 | 57,703.47% |
| Dec 31, 2021 | -96.60% |
| Dec 31, 2019 | 40.54% |
| Sep 30, 2019 | -3.01% |
| Jun 30, 2019 | -101.03% |
| Jun 30, 2013 | -200.00% |
| Jun 30, 2012 | 50.88% |
| Mar 31, 2012 | -1.09% |
| Dec 31, 2011 | 0.00% |
| Sep 30, 2011 | 42.53% |
| Jun 30, 2011 | -4.37% |